“We show increasing sales but there is still a lot of untapped potential”, says new CEO of PHI
PHI specializes in non-invasive cell analysis, enabling researchers to study cells without disrupting their natural state. The company’s products and technology are utilized by customers worldwide. Recently, PHI welcomed Anders Månsson as its new CEO. In a video interview, Månsson and Chairman of the Board Goran Dubravčić discuss the company’s future strategy and the ongoing rights issue.
Watch the full video interview with Anders Månsson and Goran Dubravčić below.
